Coeptis Therapeutics Inc.

Bull Horn Holdings Corp (Nasdaq: BHSE), sponsored by Bull Horn Holdings LLC, was a blank-check company that completed its business combination with Coeptis Therapeutics Inc., a specialty pharmaceutical and healthcare company. The SPAC priced its IPO in 2020 and announced the Coeptis merger in April 2022, targeting the healthcare sector with a focus on specialty drug development. The transaction has since closed, marking the conclusion of Bull Horn's lifecycle from IPO through deal announcement and combination. For comprehensive data on BHSE's filings, deal terms, and sponsor history, sign up for full access at SpacDesk.

SPAC Counterparty (1)